论文部分内容阅读
目的探讨安替可胶囊联合TACE治疗肝癌后患者生活质量及近期疗效的影响。方法 120例中晚期肝癌住院患者随机分为治疗组和对照组,各60例,对照组给予单纯介入治疗,治疗组采用口服安替可胶囊联合介入治疗。观察治疗后生活质量评分和近期疗效。结果治疗组能够改善患者的生活质量和提高患者的近期疗效(P<0.05)。结论安替可胶囊联合TACE治疗中晚期肝癌能明显提高肝癌介入术后患者的生活质量和提高中晚期肝癌患者的综合治疗效果。
Objective To investigate the effect of Antibiotic Capsule combined with TACE on the quality of life and the short-term curative effect of patients with liver cancer. Methods 120 patients with advanced hepatocellular carcinoma inpatients were randomly divided into treatment group and control group, 60 cases in each group. The control group received simple interventional therapy. The treatment group was treated with oral Antivac capsule combined with interventional therapy. The quality of life score and the recent curative effect were observed after treatment. Results The treatment group can improve the quality of life of patients and improve the short-term efficacy of the patients (P <0.05). Conclusions Antibiotic capsules combined with TACE in the treatment of advanced hepatocellular carcinoma can significantly improve the quality of life of patients with liver cancer after intervention and improve the comprehensive treatment of patients with advanced liver cancer.